MARKET INSIGHTS
Global (S)-2-Benzyloxycarbonylamino-pentanedioic acid 5-benzyl ester (CAS 5680-86-4) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.6 million by 2034, exhibiting a CAGR of 7.2% during the forecast period.
(S)-2-Benzyloxycarbonylamino-pentanedioic acid 5-benzyl ester, commonly known as Z-Glu(OBzl)-OH or Cbz-L-Glutamic acid 5-benzyl ester, is a protected amino acid derivative bearing a benzyloxycarbonyl (Cbz) group at the alpha‑amino position and a benzyl ester at the gamma‑carboxyl group. With a molecular formula of C20H21NO6 and a molecular weight of 371.38 g/mol, this compound serves as a key building block in peptide synthesis and pharmaceutical research, particularly in the preparation of glutamate‑containing peptide sequences and active pharmaceutical ingredients (APIs).
The market is steadily expanding, driven by rising demand in solid‑phase peptide synthesis (SPPS), growing pharmaceutical R&D investments, and the increasing development of peptide‑based therapeutics worldwide. Furthermore, the expanding role of protected amino acid derivatives in the synthesis of complex molecules for oncology, neurology, and metabolic disease research continues to support consistent demand across both academic and industrial settings.
🔟 1. Bachem Holding AG
Headquarters: Switzerland
Key Offering: Pharmaceutical‑grade protected amino acids, custom synthesis services
Bachem’s Swiss‑based operations focus on high‑purity intermediates for peptide therapeutics, leveraging advanced synthesis platforms and rigorous quality controls. The company’s portfolio includes a broad range of orthogonally protected glutamic acid derivatives, positioning it as a primary supplier for CDMOs and pharmaceutical manufacturers.
Sustainability & Growth Initiatives:
- Investment in scalable, energy‑efficient synthesis routes
- Expansion of custom synthesis capabilities to meet rising peptide‑drug demand
- Partnerships with academic research centers to accelerate novel peptide design
9️⃣ 2. Merck KGaA (Sigma‑Aldrich)
Headquarters: Germany
Key Offering: High‑purity protected amino acids, comprehensive analytical support
Merck’s Sigma‑Aldrich division supplies a full suite of protected glutamic acid derivatives, providing extensive documentation and certification for cGMP‑grade applications. The company’s integrated R&D and manufacturing pipeline ensures consistent supply and rapid turnaround for critical intermediates.
Sustainability & Growth Initiatives:
- Implementation of green chemistry protocols for protecting group synthesis
- Expansion of GMP‑compliant production lines in North America and Asia
- Collaboration with CDMOs to streamline supply chain for peptide‑based APIs
8️⃣ 3. Iris Biotech GmbH
Headquarters: Germany
Key Offering: Orthogonally protected amino acids, rapid custom synthesis
Iris Biotech specializes in catalog and custom production of Cbz‑protected glutamic acid derivatives, catering to both research laboratories and industrial manufacturers. The company’s flexible scale‑up options and rapid lead times make it a preferred partner for emerging peptide‑drug programs.
Sustainability & Growth Initiatives:
- Development of low‑waste, high‑yield protection chemistry
- Investment in automated synthesis platforms to reduce labor intensity
- Strategic alliances with CDMOs to support global peptide‑drug pipelines
7️⃣ 4. Tokyo Chemical Industry Co., Ltd. (TCI)
Headquarters: Japan
Key Offering: Fine chemical intermediates, custom synthesis services
TCI’s expertise in fine chemistry and large‑scale production of protected amino acids supports a wide range of peptide‑synthesis applications. The company’s focus on process optimization and stringent quality control ensures consistent delivery of high‑purity reagents.
Sustainability & Growth Initiatives:
- Adoption of renewable energy sources in manufacturing facilities
- Enhancement of process efficiency to reduce solvent usage
- Expansion of custom synthesis capabilities for specialty peptides
6️⃣ 5. GL Biochem (Shanghai) Ltd.
Headquarters: China
Key Offering: Cost‑effective protected amino acids, bulk production
GL Biochem has rapidly scaled its production of protected glutamic acid derivatives to meet the growing demand from Chinese and global biopharma markets. The company’s competitive pricing and efficient supply chain make it a key supplier for CDMOs and academic institutions.
Sustainability & Growth Initiatives:
- Implementation of waste‑reduction programs in synthesis operations
- Expansion of GMP‑certified production lines in Shanghai and Suzhou
- Collaboration with local universities to support peptide‑drug research
5️⃣ 6. AnaSpec, Inc.
Headquarters: USA
Key Offering: Research‑grade protected amino acids, analytical support
AnaSpec provides high‑purity protected glutamic acid derivatives for academic and industrial research. The company emphasizes rapid turnaround and detailed analytical data to support early‑stage peptide discovery.
Sustainability & Growth Initiatives:
- Use of recyclable solvents in protection chemistry
- Development of modular synthesis kits for academic laboratories
- Partnerships with biotech startups to supply custom reagents
4️⃣ 7. CPC Scientific, Inc.
Headquarters: USA
Key Offering: Custom synthesis, high‑purity intermediates
CPC Scientific delivers tailored synthesis of protected amino acids, supporting both pharmaceutical and research applications. The company’s flexible scale and rigorous QC protocols enable consistent supply for critical projects.
Sustainability & Growth Initiatives:
- Optimization of hydrogen‑olysis steps to reduce catalyst usage
- Investment in automated purification systems
- Collaboration with CDMOs to accelerate peptide‑drug development
3️⃣ 8. Senn Chemicals AG
Headquarters: Switzerland
Key Offering: Fine chemical intermediates, custom synthesis
Senn Chemicals specializes in the production of high‑purity protected amino acids, leveraging its Swiss manufacturing expertise to meet stringent GMP requirements. The company’s portfolio includes a range of Cbz‑protected glutamic acid derivatives.
Sustainability & Growth Initiatives:
- Implementation of closed‑loop solvent recovery systems
- Expansion of GMP‑qualified production capacity in Basel
- Strategic alliances with pharmaceutical R&D teams
2️⃣ 9. ChemPep Inc.
Headquarters: USA
Key Offering: Custom synthesis, research‑grade intermediates
ChemPep offers a portfolio of protected glutamic acid derivatives tailored for academic and industrial peptide synthesis. The company’s focus on rapid custom synthesis and detailed analytical data supports early‑stage discovery projects.
Sustainability & Growth Initiatives:
- Use of greener protecting group reagents
- Development of scalable synthesis protocols for large‑scale production
- Collaboration with biotech firms to supply specialized reagents
1️⃣ 10. PolyPeptide Group
Headquarters: Sweden
Key Offering: Custom synthesis, GMP‑grade intermediates
PolyPeptide Group provides high‑quality protected amino acids for pharmaceutical manufacturers and CDMOs. The company’s integrated synthesis and purification facilities ensure consistent supply of GMP‑grade reagents.
Sustainability & Growth Initiatives:
- Investment in renewable energy for production facilities
- Development of low‑energy purification processes
- Partnerships with European CDMOs to support peptide‑drug pipelines
Download FREE Sample Report: (S)-2‑Benzyloxycarbonylamino‑pentanedioic acid 5‑benzyl ester (CAS 5680‑86‑4) Market – View in Detailed Research Report
Get Full Report: (S)-2‑Benzyloxycarbonylamino‑pentanedioic acid 5‑benzyl ester (CAS 5680‑86‑4) Market – View in Detailed Research Report
Outlook: The Future of (S)-2‑Benzyloxycarbonylamino‑pentanedioic Acid 5‑Benzyl Ester Market
The trajectory of the protected glutamic acid derivative market is closely linked to the pace of peptide‑drug development. As more peptide therapeutics enter clinical pipelines—particularly in oncology, metabolic disease, and rare genetic disorders—demand for high‑purity, orthogonally protected building blocks will intensify. The trend toward integrated CDMO services and the shift to GMP‑compliant supply chains will reinforce the need for reliable, well‑documented intermediates.
Manufacturers that can deliver consistent stereochemical purity, robust documentation, and scalable production will capture the majority of the growth. Companies investing in green chemistry, energy efficiency, and advanced purification technologies are likely to outperform peers in terms of cost competitiveness and regulatory compliance.
Future Trends: Innovation Pathways for Protected Amino Acid Derivatives
- Expansion of orthogonal protection chemistries to enable multi‑step, selective deprotection in complex peptide assemblies.
- Integration of AI‑driven synthesis planning to reduce cycle times and improve yield for protected glutamic acid derivatives.
- Development of scalable, catalyst‑free hydrogenolysis processes to lower environmental footprint.
- Increased collaboration between fine‑chemical producers and CDMOs to streamline supply chains for emerging peptide‑drug candidates.
- Adoption of digital traceability systems to support regulatory requirements and supply‑chain transparency.
- Top 10 Companies in the Phenolic Resins for Building Materials Market (2026): Market Leaders Powering Global Construction - August 7, 2026
- Top 10 Companies in the Global Tetraethyl Ammonium Hydroxide Market (2026): Market Leaders Powering Chemical Applications - August 7, 2026
- Top 10 Companies in the Bio‑Based Composites Market (2026): Market Leaders Driving Sustainable Innovation - August 7, 2026